HK1205145A1 - 改進的抗體輕鏈 - Google Patents
改進的抗體輕鏈Info
- Publication number
- HK1205145A1 HK1205145A1 HK15105693.2A HK15105693A HK1205145A1 HK 1205145 A1 HK1205145 A1 HK 1205145A1 HK 15105693 A HK15105693 A HK 15105693A HK 1205145 A1 HK1205145 A1 HK 1205145A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- light chains
- antibody light
- improved antibody
- improved
- chains
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12002561 | 2012-04-11 | ||
PCT/EP2013/001065 WO2013152860A2 (en) | 2012-04-11 | 2013-04-11 | Improved antibody light chains |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1205145A1 true HK1205145A1 (zh) | 2015-12-11 |
Family
ID=48289006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15105693.2A HK1205145A1 (zh) | 2012-04-11 | 2015-06-16 | 改進的抗體輕鏈 |
Country Status (4)
Country | Link |
---|---|
US (2) | US9708388B2 (zh) |
EP (1) | EP2836512B1 (zh) |
HK (1) | HK1205145A1 (zh) |
WO (1) | WO2013152860A2 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013152860A2 (en) * | 2012-04-11 | 2013-10-17 | Dutalys Gmbh | Improved antibody light chains |
US9914785B2 (en) | 2012-11-28 | 2018-03-13 | Zymeworks Inc. | Engineered immunoglobulin heavy chain-light chain pairs and uses thereof |
CA3206122A1 (en) | 2012-11-28 | 2014-06-05 | Zymeworks Bc Inc. | Engineered immunoglobulin heavy chain-light chain pairs and uses thereof |
BR112016027888A2 (pt) | 2014-05-28 | 2017-10-24 | Zymeworks Inc | construto de polipeptídeo de ligação ao antígeno isolado, polinucleotídeo isolado ou um conjunto de polinucleotídeos isolados, vetor ou conjunto de vetores, célula isolada, composição farmacêutica, uso do construto, método para tratar um sujeito com uma doença ou distúrbio, método para obter um construto, método para preparar um construto, meio de armazenamento legível por computador, método para produzir um construto de polipeptídeo de ligação com antígeno bi-específico e método para preparar um construto de polipeptídeo de ligação com antígeno isolado |
AU2016334063B2 (en) | 2015-10-08 | 2023-05-25 | Zymeworks Bc Inc. | Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof |
AU2018292438A1 (en) | 2017-06-30 | 2019-12-12 | Zymeworks Bc Inc. | Stabilized chimeric fabs |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE219517T1 (de) | 1995-08-18 | 2002-07-15 | Morphosys Ag | Protein-/(poly)peptidbibliotheken |
EP1976991A1 (en) * | 2006-01-24 | 2008-10-08 | Domantis Limited | Fusion proteins that contain natural junctions |
EP2261254A3 (en) * | 2007-12-21 | 2011-04-13 | Amgen, Inc | Anti-amyloid antibodies and uses thereof |
US9175078B2 (en) * | 2008-01-25 | 2015-11-03 | Amgen Inc. | Ferroportin antibodies and methods of use |
CA2722600C (en) * | 2008-05-01 | 2014-01-21 | Amgen Inc. | Anti-hepcidin antibodies and methods of use |
BRPI0921320A2 (pt) | 2008-11-28 | 2018-05-22 | Abbott Laboratories | composições de anticorpo estáveis e métodos para estabilizar os mesmos |
EA022984B1 (ru) * | 2009-12-29 | 2016-04-29 | Эмерджент Продакт Дивелопмент Сиэтл, Ллс | Конструкты, связывающиеся с ron, и способы их использования |
US20130129723A1 (en) * | 2009-12-29 | 2013-05-23 | Emergent Product Development Seattle, Llc | Heterodimer Binding Proteins and Uses Thereof |
US8637641B2 (en) * | 2010-07-29 | 2014-01-28 | Xencor, Inc. | Antibodies with modified isoelectric points |
US9879072B2 (en) * | 2010-10-27 | 2018-01-30 | Amgen Inc. | DKK1 antibodies and methods of use |
CN109111524B (zh) * | 2011-10-31 | 2022-10-28 | 中外制药株式会社 | 控制了重链与轻链的缔合的抗原结合分子 |
EP2791171A1 (en) * | 2011-12-16 | 2014-10-22 | Synthon Biopharmaceuticals B.V. | EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED |
WO2013152860A2 (en) * | 2012-04-11 | 2013-10-17 | Dutalys Gmbh | Improved antibody light chains |
WO2014160499A2 (en) * | 2013-03-13 | 2014-10-02 | Creatics Llc | Methods and compositions for detecting pancreatic cancer |
-
2013
- 2013-04-11 WO PCT/EP2013/001065 patent/WO2013152860A2/en active Application Filing
- 2013-04-11 EP EP13720231.3A patent/EP2836512B1/en not_active Not-in-force
- 2013-04-11 US US14/391,853 patent/US9708388B2/en active Active
-
2015
- 2015-06-16 HK HK15105693.2A patent/HK1205145A1/zh not_active IP Right Cessation
-
2017
- 2017-06-15 US US15/623,784 patent/US10738103B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US9708388B2 (en) | 2017-07-18 |
US20170291936A1 (en) | 2017-10-12 |
EP2836512B1 (en) | 2018-10-24 |
EP2836512A2 (en) | 2015-02-18 |
US10738103B2 (en) | 2020-08-11 |
WO2013152860A2 (en) | 2013-10-17 |
US20150086538A1 (en) | 2015-03-26 |
WO2013152860A3 (en) | 2013-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2400016I1 (hu) | FCRN elleni antitestek | |
IL264558A (en) | Anti–il–23p19 antibodies | |
HK1205873A1 (zh) | 共同輕鏈小鼠 | |
HK1204571A1 (zh) | 蛋白酶調節的抗體 | |
HK1210192A1 (zh) | 抗體 | |
EP2930240A4 (en) | ANTI-FOLR1 ANTIBODY | |
ZA201407316B (en) | Anti-fgfr2 antibody | |
EP2832855A4 (en) | NEW ANTI-SIGLEC ANTIBODY-15 | |
EP2826790A4 (en) | GREMLIN-1 ANTIBODY | |
ZA201407079B (en) | Cdr-modified anti-siglec-15 antibody | |
EP2881356A4 (en) | CHAIN PULLEY | |
GB2499507B (en) | Chain | |
EP2855529A4 (en) | HUMANIZED ANTI-FACTOR B ANTIBODIES | |
HK1205145A1 (zh) | 改進的抗體輕鏈 | |
HK1210186A1 (zh) | 抗體 | |
PL2935330T3 (pl) | Przeciwciała przeciw notch3 | |
EP2927180A4 (en) | CHAIN MITTEN | |
EP2881355A4 (en) | CHAIN BLOCK | |
GB201220242D0 (en) | Antibody | |
EP2848633A4 (en) | ANTI-CXADR ANTIBODY | |
EP2811018A4 (en) | ANTI-BODY ANTI-sAPPß | |
IL235188A0 (en) | Antibodies against c-pdgf | |
AU342108S (en) | Light | |
GB201216749D0 (en) | Antigen combinations | |
GB201200568D0 (en) | Antigen combinations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230407 |